Testosterone
Also known as: Test, Test E, Test C, Test P, Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate, Testosterone Undecanoate, Testosteron, TRT, Nebido, Testoviron, Depo-Testosterone
The body's own base androgen and the foundation of practically every protocol — available in several esters that differ only in release rate, not in effect or risk profile.
Substance family
Built on the testosterone skeleton. Most convert to estradiol via aromatase, which is why estrogen management is a topic here — water retention, gynecomastia risk, and the option of an aromatase inhibitor.
Effects on
Which outcomes this substance acts on — descriptive, not a recommendation.
Strain profile
Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.
Ester variants
Same active substance, same risk profile — only release rate and injection rhythm differ. The ester determines the timing, not the effect.
| Variant | Half-life | Injection interval |
|---|---|---|
| PropionateTest P, TestovironMost controllable, but the most injections and the most pronounced injection-site pain. Useful when the recovery phase has to start on a defined date. | ~0.8–2 days | Every 1–2 days |
| EnanthateTest EThe most widely used base compound overall and the default choice in most regions. | ~4.5 days | 1–2× / week |
| CypionateTest C, Depo-TestosteroneThe default in North America. Differs from enanthate by a single carbon atom — the practical difference is negligible. | ~5–6 days | 1–2× / week |
| UndecanoateNebidoUsed almost exclusively in medical TRT. The very long interval makes dose adjustments slow and imprecise. | ~34 days | Every 10–14 weeks |
| Blend of four estersSustanon 250, OmnadrenCombines short and long esters. Has its own page because the mixed release changes both level stability and exit planning. | Mixed, ~1 to ~9 days | 1–2× / week |
The ester also determines how long the substance stays active after the last injection — relevant when planning a recovery phase.
Dosing & protocols by goal
Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.
TRT / Substitution
MedicalDose
100–200 mg / week
Frequency
1–2× / week
Cycle length
Ongoing (medically supervised)
The goal is to return to the physiological normal range, not above it. Splitting into two injections produces steadier levels than a single one.
Muscle building — Beginner
BeginnerDose
300–500 mg / week
Frequency
1–2× / week
Cycle length
12–16 weeks
Often run as the sole base compound before adding further substances. A first cycle with testosterone alone shows how the body responds before more variables enter.
Mass building — Advanced
AdvancedDose
≥ 500 mg / week (individual, open-ended)
Frequency
1–2× / week to daily
Cycle length
12–16+ weeks
Higher doses do not increase benefit linearly, but clearly raise risks and side effects — above all hematocrithematocritThe percentage of blood made up of red cells — rises on androgens and thickens the blood. and estradiolestradiolThe main estrogen — needed in men too, and damaging in both directions when out of range..
Base alongside other compounds
AdvancedDose
250–500 mg / week
Frequency
1–2× / week
Cycle length
Duration of the cycle
Non-aromatizing compounds such as trenbolone or drostanolone provide no estrogen of their own — a testosterone base is what keeps estradiolestradiolThe main estrogen — needed in men too, and damaging in both directions when out of range. functional.
Side effect & countermeasure
Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.
Problem
Elevated hematocrit / thicker blood
Countermeasure
Regular cardio and adequate hydration; donate blood if strongly elevated. Monitor via blood work (hematocrithematocritThe percentage of blood made up of red cells — rises on androgens and thickens the blood., hemoglobin). With long estersestersA chemical chain attached to a steroid to slow its release from the injection site. this develops slowly and is therefore often noticed late. Nattokinase supports fibrinolysis but does not lower the cell count — donation remains the measure that works.
Problem
Elevated blood pressure
Countermeasure
Cardio, watch salt and water balance, control weight. Medically, possibly telmisartan, amlodipine or lisinopril, and low-dose tadalafil.
Problem
Unfavorable lipid profile (HDL drops)
Countermeasure
Regular cardio, omega-3, possibly citrus bergamot; keep saturated fats moderate.
Problem
Aromatization → high estradiol (water, gyno risk)
Countermeasure
Use an aromatase inhibitoraromatase inhibitorA drug that blocks the conversion of testosterone to estradiol. only when needed and lab-guided — do not 'blindly' crash estradiolestradiolThe main estrogen — needed in men too, and damaging in both directions when out of range.. Anastrozole in the lowest effective dose; tamoxifen when breast tissue is already reacting.
Problem
Suppression of your own testosterone production (HPTA)
Countermeasure
Set a post-cycle / PCTPCTThe protocol after a cycle intended to restart the body's own testosterone production. plan before starting; the esteresterA chemical chain attached to a steroid to slow its release from the injection site. determines when it can begin. For TRT, ongoing medical supervision. HCG preserves testicular function during the cycle.
Problem
Peaks and troughs with infrequent injection
Countermeasure
A single weekly injection of a long esteresterA chemical chain attached to a steroid to slow its release from the injection site. produces noticeable swings in mood, libido and water retention. Splitting the same weekly dose into two injections evens this out at no extra cost.
Problem
Injection-site pain, especially with propionate
Countermeasure
Short estersestersA chemical chain attached to a steroid to slow its release from the injection site. irritate tissue more. Inject slowly, rotate sites systematically. Pain increasing after several days with redness and warmth indicates infection, not normal PIP — that needs a doctor.
Overview
Testosterone is the body's own principal androgen and the foundation of practically every protocol in this field. Medically it has been the gold standard for decades in treating diagnosed male hypogonadism; in the enhancement context it serves as the base compound on which everything else is built.
It is administered as an ester — testosterone itself would be broken down too quickly. The ester is an attached side chain that determines only how fast the hormone is released. That is the single most important thing to understand about the various preparations: enanthate, cypionate and propionate are the same hormone. What differs is the timing, not the effect and not the risk profile.
Mechanism of Action
Testosterone binds to the androgen receptor and thereby produces both anabolic (muscle-building) and androgenic (virilizing) effects. It is converted by the aromatase enzyme to estradiol and by 5-alpha-reductase to DHT — both metabolites have their own functions and their own side effects.
The ester itself is inactive. Only after enzymatic cleavage in the body does free testosterone become available. The length of the carbon chain determines how quickly that happens: propionate with three carbon atoms releases within days, undecanoate with eleven over weeks.
Estradiol deserves particular attention, because it is regularly misunderstood. Estrogen is not an unwanted by-product in the male body — it is needed for lipid metabolism, bone density, libido, joint comfort and mood. Too much causes water retention and gynecomastia risk; too little causes dry joints, low libido and flat mood. Both directions are a problem, which is why an aromatase inhibitor belongs in a protocol only when measurements justify it.
Choosing an Ester
The ester determines three practical things: how often you inject, how quickly a dose change takes effect, and how long the substance keeps working after the last injection.
For medical TRT and most cycles, enanthate or cypionate are the sensible default — one to two injections a week, stable levels, uncomplicated. Propionate is chosen when controllability matters: a first cycle, the final weeks of a preparation phase, or a recovery phase that has to start on a defined date.
Undecanoate is an outlier. With a half-life of over a month it is convenient in medical use but almost unusable for anything requiring adjustment — a dose change takes months to fully take effect.
What genuinely matters more than the choice of ester is the injection interval. A single weekly injection produces a pronounced peak in the first days and a corresponding trough before the next. Splitting the same weekly dose across two injections removes most of that swing without changing the total. It is the most effective adjustment available, and it costs nothing.
Typical Context
At supraphysiological doses — well above what the body produces naturally — testosterone is used to increase muscle mass and strength. In medical TRT, by contrast, doses are chosen that merely return the natural level to the normal range. These two use cases differ considerably in objective, dose height and risk profile; information about one cannot be transferred uncritically to the other.
As a base alongside other compounds, testosterone has a function beyond its own effect. Substances such as trenbolone, drostanolone or stanozolol do not aromatize and provide no estrogen of their own. Run without a testosterone base, they leave the body with no functioning estradiol level at all — which is why they are practically always combined with one.
Side Effects & Risks
- Suppression of the body's own testosterone production (HPTA axis) — even at therapeutic doses
- Aromatization to estradiol → possible water retention, gynecomastia risk
- Increase in hematocrit/hemoglobin (thickening of the blood)
- Shift in the lipid profile (tends to lower HDL)
- Elevated blood pressure
- Acne, accelerated hair loss with corresponding genetic predisposition
- Injection-site pain, particularly with short esters
- With improper injection technique: local infections, abscesses, nerve damage
Blood Work & Monitoring
Regular blood work is mandatory with any form of testosterone use, not optional. With long esters, draw at the trough — immediately before the next injection — and always at the same point, so values stay comparable.
- Total/free testosterone — trough level before the next injection
- Estradiol (sensitive) — to assess aromatization; watch both directions
- Hematocrit & hemoglobin — checking for polycythemia
- Liver values (ALT, AST, GGT)
- Lipid profile (LDL, HDL, triglycerides)
- Blood pressure — measured at home
- PSA (from the appropriate age, for prostate monitoring)
Harm-Reduction Notes
- Split the weekly dose across two injections — the simplest improvement to level stability
- Allow four to five half-lives before judging blood work; before that, levels are still climbing
- Do not crash estradiol; too low is as much a problem as too high
- Use exclusively under medical supervision and with regular lab monitoring
- Sterile single-use syringes and needles, no reuse, correct rotation of injection sites
- The origin of the product is a central risk: counterfeits and underdosing are common on the black market
- A post-cycle plan should be in place before starting — the ester determines when it can begin
Legal status by region
Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.
| Region | Regulatory status |
|---|---|
| United States | Schedule III controlled substancePrescription required; possession without one is a federal offence. |
| EU / UK | Prescription-only medicineApproved for defined medical indications; supply without prescription is an offence. |
| Canada / Australia | Controlled substance, prescription-onlyImport for personal use is restricted. |
| Parts of Asia & Latin America | Pharmacy availability variesSome countries treat it as pharmacy-dispensed rather than strictly prescription-bound. Enforcement is inconsistent and rules change. |
| Competitive sport | Prohibited at all timesListed by WADA; national anti-doping law applies in addition. |